Detalles de la búsqueda
1.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 620-631, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743851
2.
Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial.
Gynecol Oncol
; 163(3): 563-568, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34742578
3.
Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective.
Eur J Cancer
; 179: 136-146, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36563604
4.
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.
Clin Cancer Res
; 28(19): 4186-4193, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35917514
5.
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial.
Eur J Cancer
; 174: 221-231, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36067615
6.
[Efficacy and safety of gefitinib or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed previous platinum-based first-line chemotherapy].
Zhonghua Zhong Liu Za Zhi
; 33(5): 377-80, 2011 May.
Artículo
en Zh
| MEDLINE | ID: mdl-21875470
7.
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy.
Eur J Cancer
; 154: 190-200, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34293664
8.
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.
J Clin Oncol
; 38(11): 1164-1174, 2020 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073956
9.
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients.
Clin Pharmacokinet
; 58(5): 615-625, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357650
10.
Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients.
Clin Pharmacol Ther
; 105(6): 1492-1500, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30585620
11.
Technology Applications: Use of Digital Health Technology to Enable Drug Development.
JCO Clin Cancer Inform
; 2: 1-12, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30652584
12.
Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status.
J Thorac Oncol
; 9(9): 1345-53, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25122430
13.
Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials.
Drug Des Devel Ther
; 12: 347-348, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29505040
14.
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.
J Clin Oncol
; 29(8): 1067-74, 2011 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21282537
15.
A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer.
J Thorac Oncol
; 5(8): 1285-8, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20661087
16.
DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study.
J Angiogenes Res
; 1: 5, 2009 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-19946413
17.
ILD during erlotinib and gefitinib treatment in Japanese patients with non-small cell lung cancer.
J Thorac Oncol
; 5(11): 1877-8; author reply 1878, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20975386
Resultados
1 -
17
de 17
1
Próxima >
>>